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Edited by Beat ImhofAbstract Carbamylation is a post-translational modiﬁcation of
proteins characterized by the binding of cyanate to amino
groups, increased in renal failure. Pathophysiological conse-
quences of carbamylation and adverse eﬀects of carbamylated
proteins on cell functions are poorly understood. We studied
the inﬂuence of carbamylated albumin on polymorphonuclear
neutrophil (PMN) O2 production. Carbamylated albumin signif-
icantly decreased O2 production in PMNs stimulated by type I
collagen, but not by phorbol 12-myristate 13-acetate or tumor
necrosis factor-a. This eﬀect was related to inhibition of
p125FAK phosphorylation. Such an alteration of neutrophil oxi-
dative functions might explain characteristic complications of re-
nal failure, such as increased occurrence of inﬂammation or
infections.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cell functions are deeply modulated by speciﬁc interactions
with circulating or tissue proteins. For example, polymorpho-
nuclear neutrophils (PMNs) are activated by contact with
extracellular matrix (ECM) proteins such as type I collagen,
resulting in stimulation of respiratory burst and secretion of
speciﬁc enzymes [1]. However, these interactions may be im-
paired by the numerous post-translational modiﬁcations which
alter proteins in living organisms. Post-translational modiﬁca-
tions are due to the non-enzymatic binding of low molecular
weight substances (e.g. oses, lipids or their by-products) to
proteins, generating alterations of structural and functional
properties [2].Abbreviations: CRF, chronic renal failure; FAK, focal adhesion kin-
ase; PMA, phorbol 12-myristate 13-acetate; PMN, polymorphonuclear
neutrophil; TNF-a, tumor necrosis factor-a
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doi:10.1016/j.febslet.2007.03.008A relevant in vivo post-translational modiﬁcation is carba-
mylation, which is characterized by the non-enzymatic binding
of urea-derived cyanate to free amino groups of proteins, espe-
cially to e-NH2 group of lysine residues, thus generating homo-
citrulline residues [3].
Carbamylation of proteins is ampliﬁed in patients with
chronic renal failure (CRF) because of increased serum urea
concentration [4–6]. For example, it has been shown that albu-
min, the most abundant serum protein, was carbamylated dur-
ing CRF [7]. However, no studies have been devoted to the
potential involvement of carbamylated albumin in pathophys-
iological processes. Especially, interactions of carbamylated
albumin with PMNs or other inﬂammatory cells, which play
an important role in inﬂammatory processes and participate
in host defense against infections, are still unknown. Previous
works of our laboratory have shown that carbamylated type I
collagen was able to inhibit PMN oxidative functions through
a mechanism involving aLb2 integrin and subsequent p
125FAK
phosphorylation [8]. In this study, we hypothesized that carb-
amylated albumin was also able to interfere with PMN oxida-
tive functions, and addressed the question of the potential role
of circulating carbamylated proteins in the dysregulation of
PMN functions in CRF.2. Materials and methods
2.1. Materials
All chemicals were obtained from Sigma (St. Louis, MO, USA)
unless otherwise mentioned.2.2. Preparation of type I collagen
Type I collagen was prepared from Sprague–Dawley rat tail tendons
by acetic acid extraction and dissolved at 2 mg/mL in sterile 18 mM
acetic acid at 4 C [9].2.3. Preparation of PMNs
Whole blood was obtained on informed consent from healthy sub-
jects of the laboratory staﬀ. PMNs were isolated using a single-step
centrifugation procedure through a metrizoate-polyprep gradient (Ny-
comed, Oslo, Norway) at 750 g for 35 min at room temperature [9].
The PMN-rich layer was separated, washed once in Dulbecco’s solu-
tion (NaCl 137 mM, KCl 2.7 mM, HEPES 30 mM, glucose 10 mM,
CaCl2, 2 H2O 1.3 mM, MgCl2, 2 H2O 1 mM, pH 7.4) and centrifuged
at 600 · g for 15 min at room temperature. Contaminating erythro-
cytes were eliminated by hypotonic lysis in 15 mM ammonium chlo-
ride.blished by Elsevier B.V. All rights reserved.
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Human albumin (Baxter, Maurepas, France) was carbamylated by
incubation with 0.1 M KCNO in a 150 mM phosphate buﬀer, pH
7.4, at 37 C for 1, 2 or 6 h. Free KCNO was removed by extensive
dialysis against distilled water. Control series were prepared in the
presence of 0.1 M KCl according to the same protocol. Electrophoresis
of control and carbamylated albumin was performed on a 10% (m/v)
polyacrylamide gel without SDS. Amino acid analysis was carried
out by cation exchange chromatography after acid hydrolysis using a
Hitachi 8800 analyzer (ScienceTec, Les Ullis, France).
2.5. Measurement of superoxide anion ðO2 Þ production
O2 production was measured by the superoxide dismutase inhibita-
ble reduction of ferricytochrome c reaction [10]. 106 PMNs were sus-
pended in Dulbecco’s solution in presence of 0.1 lM cytochrome c.
O2 production was induced by adding: (i) type I collagen (200 lg/
mL), (ii) phorbol 12-myristate 13-acetate (PMA) (100 ng/mL), or (iii)
tumor necrosis factor-a (TNF-a) (100 ng/mL), in the presence or ab-
sence of control or carbamylated albumin (200 lg/mL). The reaction
was stopped by addition of 50 U superoxide dismutase, and absor-
bance variation at 550 nm was measured as an index of the amount
of liberated O2 . Test tubes supplemented with 50 U superoxide dismu-
tase were used as blanks assessing the speciﬁcity of the reaction. The
amount of O2 produced was calculated by using an e value of
15.5 mM1.cm1 and expressed in nmol of O2 per 10
6 cells.
2.6. Analysis of p125FAK phosphorylation
PMNs (107 cells/ml in Dulbecco’s solution) were ﬁrst preincubated
for 30 min at 20 C in the presence of 2.5 mM phenylmethylsulfonyl
ﬂuoride and 5 mM sodium orthovanadate. The temperature was raised
to 37 C for 5 min prior to the stimulation by 200 lg/mL type I colla-
gen in the presence or absence of control or carbamylated albumin
(200 lg/ml). The incubation was stopped after 2 min by centrifugation
at 1000 · g for 5 s at 4 C. The supernatants were discarded and cells
lysed by addition of 150 ll of boiled sample buﬀer (0.125 M Tris, 4%
(m/v) SDS, 10% (v/v) glycerol, 0.01% (m/v) bromophenol blue, pH
6.8). 50 ll of cell lysates were submitted to electrophoresis. Total and
phosphorylated p125FAK were evaluated by Western-blotting using
rabbit polyclonal antibodies raised against total p125FAK (Biosource,
Camarillo, CA, USA) and [Y397]phosphorylated-p125FAK (Bio-
source), respectively [8].
2.7. Statistical calculations
All experiments were performed in triplicate and the results ex-
pressed as means ± S.D. Signiﬁcance of diﬀerences was calculated
using the Student’s t-test.A B C D
+
Fig. 1. Inﬂuence of carbamylation on albumin electrophoretic mobil-
ity. 2 lg of control (A) or carbamylated albumin incubated with
KCNO for respectively 1 h (B), 2 h (C) and 6 h (D) were submitted to
10% (m/v) polyacrylamide gel electrophoresis.3. Results
3.1. Eﬀect of carbamylation on amino acid composition and
electrophoretic properties of albumin
Albumin was carbamylated by incubation with 0.1 M
KCNO for 1, 2 and 6 h at 37 C and amino acid composition
evaluated by cation exchange chromatography. Carbamyla-
tion was evidenced by the formation of homocitrulline residues
from lysine residues, in an incubation time-dependent manner
(Table 1). For example, albumin incubated for 6 h with 0.1 MTable 1
Homocitrulline content of carbamylated albumin
Control albumin Ca
Incubation time – 1 h
Homocitrulline 0 4
Lysine 101.6 ± 1.0 95
Albumin was incubated for 1, 2 or 6 h with 0.1 M KCNO (carbamylated) or
analysis was performed by cation exchange chromatography. Values are mea
1000.KCNO contained 80 residues of lysine per 1000 amino acid
residues vs. 102 in native albumin, whereas homocitrulline
contents were respectively 19 residues vs. 0 per 1000. No other
signiﬁcant change was noticed (data not shown).
When submitted to electrophoresis, carbamylated albumin
displayed a faster mobility as compared to control albumin.
The diﬀerence in electrophoretic mobility increased with carba-
mylation time, i.e. with the number of modiﬁed lysine residues
(Fig. 1). These characteristics evidenced the binding of cyanate
to lysine residues, and were further used as internal quality
control parameters in our experiments. In standard experi-
ments, preparations of albumin carbamylated for 6 h were
used.
3.2. Eﬀect of carbamylated albumin on PMN activation
In preliminary experiments performed as previously de-
scribed [8], we have checked that carbamylated albumin nei-
ther exerted a toxic eﬀect on PMNs nor modiﬁed PMNs
adhesion on type I collagen (data not shown). Subsequently,
the eﬀect of carbamylated albumin on O2 production
by PMNs was tested in the presence of three stimulators of
PMN activation : type I collagen, PMA and TNF-a. When
PMNs were stimulated by type I collagen, O2 production
was decreased by more than 70% by carbamylated albumin
(200 lg/mL), whereas control albumin had no signiﬁcant eﬀect
at the same concentration (Fig. 2A). By contrast, PMNs stim-
ulated by PMA or TNF-a showed no alteration of O2 produc-
tion, neither by control nor by carbamylated albumin at
200 lg/mL (Fig. 2B and C).
Carbamylated albumin-mediated inhibition of PMN O2
production triggered by type I collagen was dose-dependent.
No eﬀect of carbamylated albumin was found at 2 lg/mL,
whereas the inhibitory eﬀect increased with higher concentra-
tions, reaching about 12% (NS) at 20 lg/mL and 73%
(P < 0.01) at 200 lg/mL (Fig. 3A).
This eﬀect also depended on albumin carbamylation rate,
since inhibition of O2 production by PMNs was more pro-
nounced in presence of 200 lg/ml 6 h-carbamylated albuminrbamylated albumin
2 h 6 h
.5 ± 0.3 8.1 ± 0.5 19.0 ± 1.0
.4 ± 0.5 91.7 ± 0.7 80.3 ± 0.3
6 h with 0.1 M KCl (control) in phosphate buﬀer at 37 C. Amino acid
ns ± S.D. (n = 3) and expressed as number of amino acid residues per
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Fig. 2. Eﬀect of carbamylated albumin on O2 production by PMNs
stimulated by diﬀerent eﬀectors. PMNs were stimulated by 200 lg/mL
type I collagen (A), 100 ng/mL PMA (B), or 100 ng/mL TNF-a (C), in
Dulbecco’s solution without albumin (closed bar), or containing either
control (grey bars) or carbamylated (hatched bars) albumin (200 lg/
mL). O2 production was assessed by the superoxide dismutase
inhibitable reduction of cytochrome c reaction. Values are
means ± S.D. (n = 3). Statistical diﬀerences vs. series with control
albumin: NS: not signiﬁcant, ** P < 0.01.
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Fig. 3. Dose- and carbamylation rate-dependence of carbamylated
albumin-induced inhibition of PMNO2 production. O

2 production by
PMNs was induced by type I collagen (200 lg/mL) in presence of
control albumin (Ct Alb) and various concentrations (0, 2, 20 and
200 lg/mL) of 6 h-carbamylated albumin (Cb Alb) (A), or in presence
of albumin (200 lg/mL) with diﬀerent carbamylation rates (1 h (C1h),
2 h (C2h) or 6 h (C6h)) (B). O2 production was assessed by the
superoxide dismutase inhibitable reduction of cytochrome c reaction.
Values are means ± S.D. (n = 3). Statistical diﬀerences vs. series with
control albumin: NS: not signiﬁcant, *: P < 0.05, **: P < 0.01.
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Fig. 4. Eﬀect of carbamylated albumin on p125 FAK phosphorylation.
PMNs were stimulated by type I collagen (200 lg/mL) in presence or
absence of control or carbamylated albumin (200 lg/mL) for 2 min at
37 C. Total and phosphorylated p125FAK in cell lysates were analyzed
by Western-blotting using rabbit polyclonal antibodies raised against
total p125FAK and [Y397]phosphorylated-p125FAK, respectively.
S. Jaisson et al. / FEBS Letters 581 (2007) 1509–1513 1511(80%, P < 0.01) than in presence of 2 h- or 1 h- carbamylated
albumin (38%, P < 0.01 and 17%, P < 0.05, respectively)
(Fig. 3B).
No intrinsic scavenger eﬀect of carbamylated albumin was
found in a cell-free system (xanthine oxidase/hypoxanthine
system) of O2 production (data not shown).
3.3. Eﬀect of carbamylated albumin on p125FAK
phosphorylation
To investigate whether p125FAK phosphorylation was
involved in the eﬀect of carbamylated albumin on PMNs
stimulated by type I collagen, cell lysates were analyzed by
Western-blotting with a speciﬁc antibody directed against
[Y397]phosphorylated-p125FAK.
PMNs stimulated by type I collagen exhibited an increased
tyrosine phosphorylation of p125FAK when compared to
unstimulated PMNs. p125FAK phosphorylation was signiﬁ-
cantly decreased in presence of carbamylated albumin
(200 lg/mL), whereas no inhibition was noticed with control
albumin (Fig. 4).4. Discussion
Various post-translational modiﬁcations occur throughout
protein lifespan in vivo. In patients with chronic renal failure,
carbamylation of proteins occurs at an abnormal rate. This
phenomenon is the direct consequence of blood urea increase,
since this molecule spontaneously dissociates to cyanate, which
in turn binds to NH2 groups of proteins, particularly to e-NH2
groups of lysine residues to form homocitrulline residues [3].
Such a reaction has also been described after dissociation of
carbamyl phosphate into cyanate [11,12]. Increased amounts
of carbamylated proteins in blood and tissues have been well
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globin [5]. Many studies have evaluated the impact of carba-
mylation on structure and/or function of proteins, enzymes
or hormones, generating most of the time a loss of activity
or of mechanical properties [3,14,15]. Surprisingly, consider-
ably less information is available about carbamylation of albu-
min, the major circulating protein, even though the increase of
albumin carbamylation rate has been clearly demonstrated in
uremic patients [5]. Moreover, only few data are available
about the adverse eﬀects of carbamylated proteins on cell
interactions. Indeed, only one study has demonstrated that
carbamylated serum proteins could activate mesangial cells
to a proﬁbrogenic phenotype [16]. Nevertheless, we have
shown that carbamylated type I collagen, a major component
of extracellular matrix, was able to selectively regulate meta-
bolic functions of inﬂammatory cells (i.e. monocytes and
PMNs) [8,17]. Taking into account the dysregulation of leuko-
cyte functions in CRF [18], we have hypothesized that carbam-
ylated albumin could inﬂuence PMN oxidative functions, as
carbamylated collagen did.
Albumin was carbamylated in vitro by incubation at 37 C
with 0.1 M KCNO for 1–6 h. The carbamylation rate was in
agreement with that obtained for other carbamylated proteins
[16]. Moreover, the alteration of electrophoretic mobility
with incubation time is consistent with previous results [7],
and conﬁrmed the modiﬁcation of protein charge by carbamyl-
ation.
Besides the eﬀect of carbamylation on albumin composi-
tion and electrophoretic properties, we have shown that carb-
amylated albumin actually modulated PMN functions, even
at low concentration (200 lg/mL), corresponding to a modi-
ﬁcation of 0.01% of lysine residues in serum albumin. This
result is in agreement with carbamylation rates described
by Balion et al. in uremic patients [5]. Carbamylated albumin
per se had no direct eﬀect on PMN O2 production, but sig-
niﬁcantly inhibited O2 release when PMNs were stimulated
by type I collagen. Interestingly, the inhibition of PMN O2
production triggered by carbamylated albumin was carba-
mylation rate-dependent, and proved speciﬁc of type I colla-
gen activation among the stimulating agents studied: no
inhibition was observed when PMNs were stimulated by
PMA or TNF-a. Previous works of our laboratory have
shown that type I collagen was able to induce O2 production
by human PMNs through an interaction mediated by aLb2
integrin [9], thus inducing subsequent p125FAK phosphoryla-
tion [8]. Our results suggest that carbamylated albumin alters
type I collagen interaction with aLb2 integrin, since we
showed that p125FAK phosphorylation on tyrosine 397, trig-
gered by type I collagen, was strongly inhibited in presence
of carbamylated albumin. However, the inhibitory eﬀect of
carbamylated albumin on PMNs activation is independent
from any eﬀects on adhesion, as in the case of carbamylated
type I collagen [8].
In conclusion, our results suggest that carbamylation repre-
sents an important post-translational modiﬁcation of proteins
in vivo, besides glycoxidation, which occurs in CRF, diabetes
mellitus and ageing [2,19]. We have shown that carbamylated
albumin was a potent inhibitor of human PMN respiratory
burst. Our ﬁndings suggest that PMNs, which are key-cells in-
volved in host defense system through the respiratory burst,
may have a lower capacity to respond to speciﬁc stimulating
agents and to generate an inﬂammatory response in presenceof carbamylated albumin. These results could partly explain
the high occurrence of inﬂammatory and infectious complica-
tions in patients with CRF, responsible for higher morbidity
and mortality.
Acknowledgments: This work was made possible by grants from the
Centre National de la Recherche Scientiﬁque (UMR 6198), the Institut
Fe´de´ratif de Recherche 53 ‘‘Biomole´cules’’ and the University of Re-
ims Champagne-Ardenne.References
[1] Monboisse, J.C., Bellon, G., Randoux, A., Dufer, J. and Borel,
J.P. (1990) Activation of human neutrophils by type I collagen.
Requirement of two diﬀerent sequences. Biochem. J. 270, 459–
462.
[2] Harding, J.J., Beswick, H.T., Ajiboye, R., Huby, R., Blakytny, R.
and Rixon, K.C. (1989) Non-enzymic post-translational modiﬁ-
cation of proteins in aging. A review. Mech. Ageing Dev. 50, 7–
16.
[3] Kraus, L.M. and Kraus, A.P. (2001) Carbamoylation of amino
acids and proteins in uremia. Kidney Int. 78, S102–S107.
[4] Oimomi, M., Ishikawa, K., Kawasaki, T., Kubota, S., Yoshim-
ura, Y. and Baba, S. (1983) Plasma carbamylated protein in renal
failure. N. Engl. J. Med. 308, 655–656.
[5] Balion, C.M., Draisey, T.F. and Thibert, R.J. (1998) Carbamy-
lated hemoglobin and carbamylated plasma protein in hemodi-
alyzed patients. Kidney Int. 53, 488–495.
[6] Ok, E., Basnakian, A.G., Apostolov, E.O., Barri, Y.M. and Shah,
S.V. (2005) Carbamylated low-density lipoprotein induces death
of endothelial cells: a link to atherosclerosis in patients with
kidney disease. Kidney Int. 68, 173–178.
[7] Bachmann, K., Valentovic, M. and Shapiro, R. (1981) Contribu-
tion of cyanate to the albumin binding defect of uremia. Biochem.
Pharmacol. 30, 1059–1063.
[8] Jaisson, S., Lorimier, S., Ricard-Blum, S., Sockalingum, G.D.,
Delevalle´e-Forte, C., Kegelaer, G., Manfait, M., Garnotel, R. and
Gillery, P. (2006) Impact of carbamylation on type I collagen
conformational structure and its ability to activate human
polymorphonuclear neutrophil. Chem. Biol. 13, 149–159.
[9] Garnotel, R., Monboisse, J.C., Randoux, A., Haye, B. and Borel,
J.P. (1995) The binding of type I collagen to lymphocyte function-
associated antigen (LFA) 1 integrin triggers the respiratory burst
of human polymorphonuclear neutrophils. J. Biol. Chem. 270,
27495–27503.
[10] English, D., Roloﬀ, J.S. and Lukens, J.N. (1981) Regulation of
human polymorphonuclear leukocyte superoxide release by cel-
lular responses to chemotactic peptides. J. Immunol. 126, 165–
171.
[11] Ramponi, G., Leaver, J.L. and Grisolia, S. (1971) Homocitrulline
formation following carbamylation of histones with carbamyl
phosphate. FEBS Lett. 16, 311–314.
[12] Chapman, C.E. and Simons, E.R. (1977) Conformational changes
induced by the addition of carbamyl phosphate to sickle cell
hemoglobin. Biochim. Biophys. Acta 494, 408–415.
[13] Kraus, L.M., Gaber, L., Handorf, C.R., Marti, H.P. and Kraus,
A.P. (2001) Carbamoylation of glomerular and tubular proteins
in patients with kidney failure: a potential mechanism of ongoing
renal damage. Swiss Med. Wkly. 131, 139–144.
[14] Mun, K.C. and Golper, T.A. (2000) Impaired biological activity
of erythropoietin by cyanate carbamylation. Blood Purif. 18, 13–
17.
[15] Jaisson, S., Larreta-Garde, V., Bellon, G., Hornebeck, W.,
Garnotel, R. and Gillery, P. (2006) Carbamylation diﬀerentially
alters type I collagen sensitivity to various collagenases. Matrix
Biol., doi:10.1016/j.matbio.2006.10.008.
[16] Shaykh, M., Pegoraro, A.A., Mo, W., Arruda, J.A., Dunea, G.
and Singh, A.K. (1999) Carbamylated proteins activate glomer-
ular mesangial cells and stimulate collagen deposition. J. Lab.
Clin. Med. 133, 302–308.
[17] Garnotel, R., Sabbah, N., Jaisson, S. and Gillery, P. (2004)
Enhanced activation of and increased production of matrix
S. Jaisson et al. / FEBS Letters 581 (2007) 1509–1513 1513metalloproteinase-9 by human blood monocytes upon adhering to
carbamylated collagen. FEBS Lett. 563, 13–16.
[18] Vanholder, R. and Ringoir, S. (1993) Infectious morbidity and
defects of phagocytis function in end-stage renal failure disease: a
review. J. Am. Soc. Nephrol. 3, 1541–1554.[19] Monboisse, J.C., Rittie´, L., Lamfarraj, H., Garnotel, R. and
Gillery, P. (2000) In vitro glycoxidation alters the interactions
between collagens and human polymorphonuclear leucocytes.
Biochem. J. 350, 777–783.
